News
Barclays is shaking up its investment bankagain. Over 200 roles are on the chopping block, mostly at the managing director ...
US stock futures traded flat as investors anticipated the second day of renewed trade talks between the US and China after an ...
FEPI's 28% yield is eye-catching, but its aggressive covered call strategy leads to significant price erosion and downside ...
That latter motive helped Nvidia (NVDA) advance more than 2% in Monday's morning session before reducing to a less than 1% ...
The iShares Semiconductor ETF offers broad exposure to US-listed semiconductor companies, avoiding concentration. Click here ...
Navigate potential Nasdaq weakness as key indicators hint at consolidation. Learn why experts suggest protecting gains with ...
Polen Capital, an investment management company, released its “Polen US SMID Company Growth Strategy” first-quarter 2025 ...
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly ...
S&P 500 futures traded near the benchmark's record highs as talks provide a glimmer of hope for a US-China trade deal.
Trump call for JJ to cut rates by 100 bps next week. CPI and PPI due out this week – what will it reveal? The FOMC meeting b ...
The second-round of meetings comes four days after U.S. President Donald Trump and Chinese leader Xi Jinping spoke by phone, ...
Launched on 02/05/2001, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results